— Know what they know.
Not Investment Advice
Also trades as: XVIVO.ST (STO) · $vol 1M · 0RKL.L (LSE) · $vol 0M · XVIPF (OTC) · $vol 0M

XVIPY OTC

Xvivo Perfusion AB (publ)
1W: -13.2% 1M: -29.1% YTD: -15.9%
$5.50
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Devices · Tech Score Sell · Power 41 · $693.0M mcap · 40M float · 0.0014% daily turnover · Short 82% of daily vol
Smart Money Score
No convergence signal
Key Statistics
Market Cap$693.0M
52W Range4.25-8.18
Volume1,000
Avg Volume570
Beta1.78
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOChristoffer Rosenblad
Employees210
SectorHealthcare
IndustryMedical - Devices
IPO Date2022-09-23
MAessans gata 10
Mölndal, VG 431 53
SE
46 3 17 88 21 50
About Xvivo Perfusion AB (publ)

Xvivo Perfusion AB (publ), a medical technology enterprise based in Gothenburg, Sweden, specializes in developing cutting-edge solutions for the preservation and perfusion of organs, tissues, and cells, crucial for transplantation. The company's reach spans diverse global markets, including Sweden, the United States, broader North and South America, Europe, the Middle East, Africa, and the Asia Pacific region. Its extensive product lineup features the XVIVO System (XPS), an integrated, ready-to-use cardiac bypass system engineered for secure normothermic ex vivo lung perfusion (EVLP). This is supported by the XPS Disposable Lung Kit, which supplies all necessary sterile consumables. Xvivo Perfusion also provides STEEN Solution, a uniquely formulated buffered extracellular solution for perfusing isolated donor lungs during EVLP procedures. Further offerings include Perfadex Plus, an extracellular, low-potassium, dextran-based electrolyte preservation solution; the XVIVO Silicone Tubing Set for rapid flushing of donor lungs during the procurement phase; and both the XVIVO LS and XVIVO Disposable Lung Set, specialized devices for EVLP. Additionally, the company offers the XVIVO Organ Chamber, a single-use sterile container designed for the temporary holding of isolated lungs before transplantation into a recipient, alongside the XVIVO Lung Cannula Set, another sterile, single-use disposable product. The company was founded in 1998.

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms